OSR Health, Inc.

Item 8.01. Other Events. On August 27, 2026, the Company was notified that the Nasdaq Hearings Panel (the “Panel”) has scheduled the Company’s hearing for September 29, 2026 at 10:00 a.m. Eastern Time. As previously reported, the Company submitted its hearing request on August 25, 2026, appealing the Staff’s delisting determination and requesting the continued listing of its securities on Nasdaq. As previously disclosed, the timely hearing request did not stay the suspension of trading in the Company’s securities, which took effect at the opening of business on August 26, 2026; however, the timely hearing request stayed the filing of a Form 25-NSE, and therefore the formal delisting of the Company’s securities from listing and registration on Nasdaq, pending the issuance of the Panel’s decision. The Company is preparing its presentation to the Panel and intends to present a comprehensive plan to regain and sustain compliance with the applicable Nasdaq continued listing requirements. The Company is preparing diligently for the hearing, at which we intend to advocate vigorously for the Company’s continued listing of its securities on Nasdaq. The Company notes that there can be no assurance that the Panel will grant the Company’s request for continued listing or that the Company will regain compliance with Nasdaq’s listing requirements.